The incidence of the secondary hyperparathyroidism (HPT) after parathyroidectomy (PTE) in dialysis patients accounts for 10-80%. We present a case of the successful cinacalcet treatment of a female hemodialysis (HD) patient with HPT relapse. A female patient (aged 40 years) with the diabetes mellitus I (since 11 years of age) has been undergoing substitution therapy on continuous ambulatory peritoneal dialysis (CAPD) since October 2004. Insulin and erythropoietin treatment has been continued as well as taking phosphate binders with calcium and calcitriol analogs (with intervals due to hyperphosphatemia). Нb=117g/L, Са=2.2, Р=1.8mmoles/L, PTH=272pg/ml, total alkaline phosphatase (AlP)=69 U/L (normal level 31-115), and Нb1С=9.2%. Since Decemb...
Introduction Secondary hyperparathyroidism (SHPT) develops in patients with chronic renal failure. C...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
The aim of this study was to investigate the effects of cinacalcet therapy on anemia parameters, bon...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...
BACKGROUND: Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients receiv...
In Belgium, the calcimimetic cinacalcet is initially reimbursed for ≤ 4 months in dialysis patients ...
The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidi...
In Belgium, the calcimimetic cinacalcet is initially reimbursed for months in dialysis patients with...
Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiv...
Abstract Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, c...
Secondary hyperparathyroidism is a common complication of chronic kidney disease. The elevated seru...
AbstractBackgroundThe effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary...
Abstract Introduction: Secondary hyperparathyroidism is the target of several therapeutic strategie...
Background. Secondary hyperparathyroidism (sHPT) is one of the serious complications in chronic kidn...
Background Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (...
Introduction Secondary hyperparathyroidism (SHPT) develops in patients with chronic renal failure. C...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
The aim of this study was to investigate the effects of cinacalcet therapy on anemia parameters, bon...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...
BACKGROUND: Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients receiv...
In Belgium, the calcimimetic cinacalcet is initially reimbursed for ≤ 4 months in dialysis patients ...
The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidi...
In Belgium, the calcimimetic cinacalcet is initially reimbursed for months in dialysis patients with...
Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiv...
Abstract Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, c...
Secondary hyperparathyroidism is a common complication of chronic kidney disease. The elevated seru...
AbstractBackgroundThe effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary...
Abstract Introduction: Secondary hyperparathyroidism is the target of several therapeutic strategie...
Background. Secondary hyperparathyroidism (sHPT) is one of the serious complications in chronic kidn...
Background Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (...
Introduction Secondary hyperparathyroidism (SHPT) develops in patients with chronic renal failure. C...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
The aim of this study was to investigate the effects of cinacalcet therapy on anemia parameters, bon...